Phase II study of amrubicin for previously treated patients with malignant pleural mesothelioma.

被引：0

作者：

Akagi, Kazumasa

Ikeda, Takaya

Nakatomi, Katsumi

Taniguchi, Hirokazu

Shimada, Midori

Gyotoku, Hiroshi

Dotsu, Yosuke

Umeyama, Yasuhiro

Tomono, Hiromi

Kitazaki, Takeshi

Fukuda, Masaaki

Soda, Hiroshi

Senju, Hiroaki

Takemoto, Shinnosuke

Yamaguchi, Hiroyuki

Fukuda, Minoru

Mukae, Hiroshi

机构：

[1] Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan

[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[3] Ureshino Med Ctr, Dept Resp Med, Ureshino, Japan

[4] Sasebo City Gen Hosp, Dept Resp Med, Sasebo, Japan

[5] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Resp Med, Nagasaki, Japan

[6] Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e21095

引用

页数：2